- Home
- MTEN vs VNRX Comparison
MTEN vs VNRX Comparison
Compare MTEN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- VNRX
- Stock Information
- Founded
- MTEN 2015
- VNRX N/A
- Country
- MTEN China
- VNRX United States
- Employees
- MTEN N/A
- VNRX N/A
- Industry
- MTEN Building Products
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MTEN Industrials
- VNRX Health Care
- Exchange
- MTEN Nasdaq
- VNRX Nasdaq
- Market Cap
- MTEN 82.6M
- VNRX 69.7M
- IPO Year
- MTEN 2024
- VNRX N/A
- Fundamental
- Price
- MTEN $3.95
- VNRX $0.45
- Analyst Decision
- MTEN
- VNRX Strong Buy
- Analyst Count
- MTEN 0
- VNRX 4
- Target Price
- MTEN N/A
- VNRX $3.50
- AVG Volume (30 Days)
- MTEN 81.5K
- VNRX 334.2K
- Earning Date
- MTEN 10-01-2025
- VNRX 11-13-2025
- Dividend Yield
- MTEN N/A
- VNRX N/A
- EPS Growth
- MTEN N/A
- VNRX N/A
- EPS
- MTEN N/A
- VNRX N/A
- Revenue
- MTEN $10,735,337.00
- VNRX $1,319,252.00
- Revenue This Year
- MTEN N/A
- VNRX $324.32
- Revenue Next Year
- MTEN N/A
- VNRX $247.82
- P/E Ratio
- MTEN N/A
- VNRX N/A
- Revenue Growth
- MTEN 16.63
- VNRX 35.10
- 52 Week Low
- MTEN $3.20
- VNRX $0.40
- 52 Week High
- MTEN $26.03
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- MTEN 22.42
- VNRX 28.74
- Support Level
- MTEN $4.62
- VNRX $0.63
- Resistance Level
- MTEN $5.88
- VNRX $0.67
- Average True Range (ATR)
- MTEN 1.29
- VNRX 0.04
- MACD
- MTEN -0.27
- VNRX -0.02
- Stochastic Oscillator
- MTEN 2.57
- VNRX 3.69
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.